BRX011
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BRX011, covering 2025-06-26 to 2025-06-26. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration [Phase 1, Phase 2]